Study offers insights on why the elderly are more susceptible to COVID-19
The Pharma Data
NOVEMBER 9, 2021
Elias, an immunologist and dean of medicine and biological sciences at Brown. The researchers thought they might be able to take some of the work they’ve already done with this gene family and apply it to COVID-19, Elias said. “This means there will be less infection in the presence of this therapeutic FRG antibody.”
Let's personalize your content